Rocket Pharmaceuticals Correlations

RCKT Stock  USD 3.77  0.07  1.89%   
The current 90-days correlation between Rocket Pharmaceuticals and Autolus Therapeutics is 0.22 (i.e., Modest diversification). The correlation of Rocket Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Rocket Pharmaceuticals Correlation With Market

Average diversification

The correlation between Rocket Pharmaceuticals and DJI is 0.16 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Rocket Pharmaceuticals and DJI in the same portfolio, assuming nothing else is changed.
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Rocket Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
For more information on how to buy Rocket Stock please use our How to Invest in Rocket Pharmaceuticals guide.

Moving together with Rocket Stock

  0.71XNCR Xencor IncPairCorr
  0.67MNMD Mind MedicinePairCorr
  0.61PTCT PTC TherapeuticsPairCorr
  0.74RLAY Relay Therapeutics Earnings Call This WeekPairCorr
  0.63RPTX Repare Therapeutics Earnings Call This WeekPairCorr
  0.67BCAX Bicara TherapeuticsPairCorr
  0.64TNGX Tango Therapeutics Earnings Call This WeekPairCorr
  0.65SSNLF Samsung ElectronicsPairCorr
  0.65UNFI United Natural FoodsPairCorr
  0.64AEP American Electric PowerPairCorr
  0.65VRT Vertiv HoldingsPairCorr

Moving against Rocket Stock

  0.71FBLG FibroBiologics, CommonPairCorr
  0.43KMDA KamadaPairCorr
  0.35GENI Genius SportsPairCorr

Related Correlations Analysis


Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

ADCTRAPT
KRRORAPT
ADCTFDMT
RAPTFDMT
KRROADCT
DBVTFDMT
  

High negative correlations

KRROAUTL
ADCTAUTL
RAPTAUTL
FDMTAUTL
INBXAUTL
INBXSLDB

Risk-Adjusted Indicators

There is a big difference between Rocket Stock performing well and Rocket Pharmaceuticals Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Rocket Pharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
AUTL  3.74 (0.57) 0.00 (1.84) 0.00 
 7.09 
 24.79 
MBX  6.44  1.21  0.21  0.79  5.42 
 11.28 
 113.78 
FDMT  5.29  1.73  0.34 (9.59) 4.06 
 14.53 
 61.05 
RAPT  4.09  1.38  0.35  0.55  3.67 
 13.89 
 25.29 
SLDB  3.34 (0.48) 0.00 (0.13) 0.00 
 5.89 
 24.34 
ADCT  3.01  0.58  0.18  0.41  3.12 
 6.13 
 20.98 
INBX  4.75  1.95  0.47  0.44  3.37 
 7.53 
 100.12 
ALMS  2.47  0.13  0.05  0.23  2.50 
 6.01 
 14.97 
DBVT  3.33  0.76  0.27  0.61  2.38 
 9.53 
 29.01 
KRRO  5.72  1.44  0.28  0.57  4.90 
 12.24 
 31.66 

Rocket Pharmaceuticals Corporate Management

CPA CPAVP, OfficerProfile
Mayo PujolsChief OfficerProfile
Christopher StevensChief OfficerProfile
Martin JDSecretary, CounselProfile
Carlos MartinChief OfficerProfile
Sarbani MBAChief OfficerProfile
Jonathan SchwartzChief Medical OfficerProfile